FRI0314 Safety of the Newer Biological Dmards, TOCILIZUMAB and Abatacept, in Rheumatoid Arthritis (RA) Patients with A History of HBV Infection: A REAL Life Experience

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 499.1-499 ◽  
Author(s):  
F. De Nard ◽  
M. Todoerti ◽  
V. Grosso ◽  
S. Rossi ◽  
R. Caporali ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Life Experience ◽  
Real Life ◽  
Hbv Infection ◽  
Biological Dmards ◽  
History Of

Unmet needs in the treatment of rheumatoid arthritis. An observational study and a real-life experience from a single university center

2019 ◽  
Vol 48 (4) ◽  
pp. 597-602 ◽  
Author(s):  
Evripidis Kaltsonoudis ◽  
Eleftherios Pelechas ◽  
Paraskevi V. Voulgari ◽  
Alexandros A. Drosos
Keyword(s):  
Rheumatoid Arthritis ◽  
Observational Study ◽  
Unmet Needs ◽  
Life Experience ◽  
Real Life ◽  
University Center

Biologics registries

2013 ◽  
pp. 257-263
Author(s):  
David Isenberg ◽  
Angela Zink
Keyword(s):  
Rheumatoid Arthritis ◽  
Life Experience ◽  
Real Life ◽  
Cancer Development ◽  
Controlled Trials ◽  
Side Effect Profile ◽  
Risk Of Infection ◽  
Biologic Drugs ◽  
Double Blind

Double-blind controlled trials undertaken over the past two decades have established the short-term effectiveness and side-effect profile of biologic drugs for patients with rheumatoid arthritis and related diseases. However, the development of biologics registers to capture ’real-life experience’ and explore long-term effectiveness and complications is equally important. In this chapter, we demonstrate how these registers have identified long-term joint benefits, a reduction in cardiovascular mortality, reassurance concerning fears about cancer development, and a balanced view of the risk of infection.

AB0441 Abatacept in Rheumatoid Arthritis (RA) Patients: Real-Life Experience in A Subregional Centre in Uk

2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 954.1-954
Author(s):  
N. Ahmed ◽  
S. Roskell ◽  
K. Passey ◽  
B. Lloyd ◽  
S. Raghuvanshi ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Life Experience ◽  
Real Life

scholarly journals Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience

Rheumatology ◽  
2007 ◽  
Vol 46 (6) ◽  
pp. 980-982 ◽  
Author(s):  
R. N. Jois ◽  
A. Masding ◽  
M. Somerville ◽  
K. Gaffney ◽  
D. G. I. Scott
Keyword(s):  
Rheumatoid Arthritis ◽  
Life Experience ◽  
Real Life

scholarly journals Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry

2014 ◽  
Vol 2014 ◽  
pp. 1-8 ◽  
Author(s):  
Matteo Filippini ◽  
Chiara Bazzani ◽  
Fabiola Atzeni ◽  
Piercarlo Sarzi Puttini ◽  
Antonio Marchesoni ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Marked Improvement ◽  
Real Life ◽  
Tnf Alpha ◽  
First Year ◽  
Life Data ◽  
Highly Active ◽  
Real Life Data ◽  
History Of

This study involving 1033 patients with RA confirms the effectiveness of etanercept, adalimumab, and infliximab in reducing RA-related disability even in patients with a history of highly active and longstanding RA. Moreover, we found that the improvement in disability was biphasic, with a marked improvement during the first year of anti-TNF therapy, followed by slower but significant recovery over the subsequent four years.

AB0372 Treatment To Target Following Initiation of Treatment with Rituximab in Rheumatoid Arthritis: Real Life Experience

2016 ◽  
Vol 75 (Suppl 2) ◽  
pp. 1031.1-1031
Author(s):  
R. Ionescu ◽  
M. Ismajli ◽  
S. Moore ◽  
G. Cambridge ◽  
M. Leandro
Keyword(s):  
Rheumatoid Arthritis ◽  
Life Experience ◽  
Real Life
Sign in / Sign up

Export Citation Format

Share Document